The modest EPS beat is priced in given no stock reaction, but absence of revenue data and lack of guidance update limit near-term catalysts. Monitor the April 28 call for commentary on pipeline progress or cash runway.
Price Chart
Executive Summary
Wave Life Sciences (WVE) announced it will report first-quarter 2026 financial results on April 28, 2026, via a live webcast and conference call. The release confirms an EPS beat of 4.3% ($-0.30 vs. $-0.31 estimate) but provides no revenue figure for the quarter, only noting consensus expected $7.9M.
Key Financial Metrics
Key Facts
- Company to report Q1 2026 financial results on April 28, 2026
- EPS of $-0.30 reported, a 4.3% beat versus consensus of $-0.31
- No actual revenue figure disclosed for Q1 2026; consensus expected $7.9M
- No guidance update or material business developments announced
Financial Impact
EPS beat by $0.01 (4.3%) vs. consensus; revenue not disclosed
Risk Factors
- No revenue data disclosed, limiting full assessment of performance
- Biotech sentiment and lack of near-term catalysts may pressure stock
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3278945 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Insider Cluster | $5.41 $4.58 | ▼ −15.34% | ▼ −13.35% | $3.80 (−29.85%) |
May 18, 2026 19w ago | Press Release | $6.14 $5.95 | ▼ −3.09% | ▼ −4.08% | $3.80 (−38.19%) |
Apr 28, 2026 22w ago | 8-K | $7.52 $6.34 | ▼ −15.69% | ▼ −21.15% | $3.80 (−49.53%) |
Apr 28, 2026 22w ago | Press Release | $7.52 $6.38 | ▼ −15.16% | ▼ −20.63% | $3.80 (−49.53%) |
Apr 22, 2026 23w ago | Press Release | $7.38 $6.14 | ▼ −16.80% | ▼ −19.97% | $3.80 (−48.58%) |
Apr 15, 2026 24w ago | DEFA14A | $7.32 $6.99 | ▼ −4.51% | ▼ −10.32% | $3.80 (−48.16%) |
Apr 15, 2026 24w ago | 8-K | $7.32 $6.99 | ▼ −4.51% | ▼ −10.32% | $3.80 (−48.16%) |
Mar 26, 2026 27w ago | Press Release | $6.20 $7.18 | ▲ +15.81% | ▲ +5.14% | $3.80 (−38.79%) |
Feb 26, 2026 31w ago | 8-K | $15.36 $6.20 | ▼ −59.64% | ▼ −53.23% | $3.80 (−75.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access